$FOXA 21St Century Fox Class A (FOXA) Overall Average: 64% Sell.

Jenna King's Return Elevates Local Care Who says you can't go home again? Jenna King, a familiar face in Southeast Kansas, is back to serve her community by upping the ante in dermatology care at U.S. Dermatology Partners in Pittsburg. After gaining experience in Oklahoma, she's here to extend both medical and cosmetic treatments to her neighbors. Why Her Return Is a Game...

Anthropic's IPO Sparks Direxion's Latest ETF Moves Alright, folks, Anthropic's public filing for an IPO isn't just turning heads—it's lighting up the trading floor! Following this buzz, Direxion grabs its chance to unleash two new ETFs designed to seize on Anthropic's rollercoaster debut. We're talking about the Direxion Daily Anthropic Bull 2X ETF (ANTO) and the...

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

What's Brewing at Entangled 2026? Innovation's got a new haunt come November, and it’s sprouting right in Cambridge's Kendall Square. LabCentral, C10 Labs, and Innovation Centre Denmark Boston have concocted something here for the curious minds: Entangled 2026. Picture over 250 movers and shakers from biotech, deep tech, investment, academia, and more, gathering under...

Pozdeutinurad's Phase 3 Triumph Ah, the life of biotech—constant ups and downs, but when you hit a homerun, it feels like the market stands still for a second. Pozdeutinurad's recent Phase 3 REDUCE-2 study results are one of those moments for Swedish Orphan Biovitrum AB, or Sobi for short. This study showed some seriously compelling data: clinically meaningful and...

Barrett Gets in the Game with P.S. Active Alright, picture this: an activewear brand hooked up with a logistics heavyweight. No, it's not just another round of corporate muscle-flexing—it's P.S. Active, spearheaded by Erika Hammond, partnering with Barrett Distribution Centers to elevate their fulfillment game from New Jersey's Somerset hub. The Stakes: More Than Just...

From Sticker Dreams to Racing Reality Some days bring surprises outside the typical ticker watch as those market charts get shoved aside, right when fans' stories race onto the scene. What McLaren and Velo cooked up for the Mexico City Grand Prix has got me pausing—a blend of motorsport passion and grassroots creativity. By unveiling the 'Livery of Dreams,' McLaren puts...

Stock Turbulence Hits ServiceNow Investors Wake up and smell the market correction! ServiceNow's done slapped its shareholders with a situation no one saw coming—or maybe not. When the market opened on October 29, NYSE:NOW shares weren't just dipping; they were diving off a $29 cliff, all thanks to some sour guidance for fourth-quarter growth. Talk about financial...

Healthy Gains in Revenues and Profits Well, Cat Financial's latest report is another piece of the puzzle showing steady, if not spectacular, growth. They've jacked up their revenues by 10% for the third quarter of 2026 compared to last year's same stretch. This puts the revenues at $1.02 billion, a $95 million bump from the previous year. Pretty impressive. The profit saw...

A Dazzling Holiday Transformation Awaits Forget the mundane holiday light displays. Busch Gardens is cranking it up a notch with their annual Christmas Town spectacle, kicking off on November 13. With two parks—Tampa Bay and Williamsburg—each delivering a unique experience, prepare for an immersive dive into holiday cheer that's packed with glitz, entertainment, and,...

PharmaTher's Roadmap to Ketamine Commercialization PharmaTher Holdings Ltd. (the "Company" or "PharmaTher") (OTCQB: PHRRF) (CSE: PHRM), a pioneering specialty pharmaceutical firm, is steering its focus towards the development and commercialization of ketamine-based therapies. The Company has carved out an impressive path for itself as it aspires to lead in unlocking the...

The Rise of AI Governance in a Chaotic Landscape Here we are, on the cusp of a tech revolution where regulations are starting to tighten around AI like a vise. You remember those wild days back during the dot-com boom, right? Everyone was scrambling to cash in on tech, while the ground rules were still being drawn up. Well, history's repeating itself—only this time,...

Parsons Corporation's Upcoming Conference Presentation Parsons Corporation will soon take the stage at a significant financial event known as the Raymond James 46th Annual Institutional Investors Conference. This prestigious conference is an excellent opportunity for the company to engage with investors and provide insights into its strategic direction. Featured Speakers...

Revolutionizing Mud Pan Cleaning with Innovative Design Meet a groundbreaking solution for home renovation enthusiasts and professionals alike—an inventive tool designed specifically for cleaning mud pans efficiently and effectively. This innovative product stems from the extensive experience of a skilled drywall finisher who spent 40 years in the industry, identifying...

Brookfield Asset Management Achieves New Heights with BAM Stock Brookfield Asset Management Inc (TSX: BAM) recently celebrated a major milestone as its stock reached an impressive 52-week high of $47.45. This achievement demonstrates the company’s strong growth trajectory and effective strategies in place. Investors are showing increased confidence in BAM’s unique...